Accelr8 Technology Corporation (AXK) Announces Initial Results from ICU Pilot Clinical Study for Same-Day, Multi-Organism, Multi-Resistance Diagnostics Presented at American Thoracic Society
5/17/2011 9:29:35 AM
DENVER--(BUSINESS WIRE)--Accelr8 Technology Corporation (NYSE Amex: AXK) announced that clinical investigators led by Ivor S. Douglas, MD/FRCP (UK) from Denver Health presented initial ICU pilot study results at the 2011 ATS International Conference. The American Thoracic Society (ATS, www.thoracic.org) is a leading organization for physician specialists in Pulmonary Medicine and Critical Care Medicine. ATS is holding its annual meeting this year in Denver, from May 13-18.
comments powered by